![Mervyn Turner](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mervyn Turner
Vorsitzender bei
Lunac Therapeutics Ltd.
Profil
Mervyn J.
Turner is the founder of PrescribeWell, Inc. Current jobs include Chairman at Lunac Therapeutics Ltd., Director at PharmAkea, Inc., Director at EnGeneIC Pty Ltd., Director at Spinogenix, Inc., Director at Amydis, Inc., Director at SAB Sciences, Inc. since 2020, and Board of Strategic Advisor at Excel Medical Ventures LLC.
Former jobs include Director at Preventice Technologies, Inc., Director at Tunitas Therapeutics, Inc., Independent Director at Big Cypress Acquisition Corp., Independent Director at SAB Biotherapeutics, Inc., Independent Director at Adagene, Inc. from 2023 to 2025, Chief Strategy Officer & Senior Vice President at Merck & Co., Inc. in 2011, Chief Strategy Officer at Schering-Plough Corp.
in 2009, Advisor at Quaker Partners Management LP, and Chief Strategy Officer & SVP-Worldwide Licensing at Merck Sharp & Dohme Corp.
from 1999 to 2009.
Education includes a doctorate from The University of Sheffield.
Aktive Positionen von Mervyn Turner
| Unternehmen | Position | Beginn |
|---|---|---|
Excel Medical Ventures LLC
 Excel Medical Ventures LLC Investment ManagersFinance Excel Medical Ventures invests in companies located in the United States. The firm focuses on companies operating in agriculture, energy, materials, IT, defense, healthcare sectors such as healthcare IT & services, diagnostics, medical devices, and life sciences platforms. It participates in early to late stage transactions. | Berater | - |
PharmAkea, Inc.
 PharmAkea, Inc. Pharmaceuticals: MajorHealth Technology Develops small molecule drug candidates against protein targets involved in fibroproliferative diseases | Direktor/Vorstandsmitglied | - |
EnGeneIC Pty Ltd.
 EnGeneIC Pty Ltd. BiotechnologyHealth Technology Develops and commercializes novel concepts for the targeted delivery of drugs and other therapeutic molecules used in the treatment of cancer | Direktor/Vorstandsmitglied | - |
SAB Sciences, Inc.
 SAB Sciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical development company | Direktor/Vorstandsmitglied | 16.12.2020 |
Lunac Therapeutics Ltd.
 Lunac Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Engages in identification and development of anticoagulants | Vorsitzender | - |
Amydis, Inc.
 Amydis, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a pharmaceutical company that focused on developing chemistry to detect diseases | Direktor/Vorstandsmitglied | - |
Spinogenix, Inc.
 Spinogenix, Inc. Pharmaceuticals: MajorHealth Technology Develops neurorestorative therapeutics | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Mervyn Turner
| Unternehmen | Position | Ende |
|---|---|---|
| ADAGENE INC. | Direktor/Vorstandsmitglied | 24.03.2025 |
| MERCK & CO., INC. | Corporate Officer/Principal | 03.10.2011 |
| ░░░░░░ ░░░░░░░░ ░░░░░░░░░░ ░░ | ░░░░░░░ ░░░░░░ ░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░░░░░░ ░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░ ░░░░░ ░░░░░ ░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Ausbildung von Mervyn Turner
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
77
Beziehungen ersten Grades
18
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 18 |
|---|---|
Merck & Co., Inc.
 Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
Schering-Plough Corp.
 Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Manufactures and sells pharmaceutical & health care products | Health Technology |
Preventice Technologies, Inc.
 Preventice Technologies, Inc. Packaged SoftwareTechnology Services Develops mobile health and wellness platform solutions | Technology Services |
PharmAkea, Inc.
PharmAkea, Inc. Pharmaceuticals: MajorHealth Technology Develops small molecule drug candidates against protein targets involved in fibroproliferative diseases | Health Technology |
Quaker Partners Management LP
 Quaker Partners Management LP Investment ManagersFinance Quaker Partners Management invests in healthcare companies located in the United States primarily in East Coast. The firm targets companies operating in the fields of biopharmaceuticals, medical devices, human diagnostics, specialty pharmaceuticals and healthcare services. It participates in seed and early stage capital requirements. | Finance |
The University of Sheffield
 The University of Sheffield Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Excel Medical Ventures LLC
Excel Medical Ventures LLC Investment ManagersFinance Excel Medical Ventures invests in companies located in the United States. The firm focuses on companies operating in agriculture, energy, materials, IT, defense, healthcare sectors such as healthcare IT & services, diagnostics, medical devices, and life sciences platforms. It participates in early to late stage transactions. | Finance |
EnGeneIC Pty Ltd.
EnGeneIC Pty Ltd. BiotechnologyHealth Technology Develops and commercializes novel concepts for the targeted delivery of drugs and other therapeutic molecules used in the treatment of cancer | Health Technology |
Tunitas Therapeutics, Inc.
 Tunitas Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops protein therapeutics for the treatment of allergy | Health Technology |
Merck Sharp & Dohme Corp.
 Merck Sharp & Dohme Corp. Pharmaceuticals: MajorHealth Technology Develops and markets pharmaceutical products | Health Technology |
Adagene, Inc.
 Adagene, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company which discovers and develops novel antibody-based cancer immunotherapies | Health Technology |
PrescribeWell, Inc.
 PrescribeWell, Inc. Medical/Nursing ServicesHealth Services Provides an online health management system | Health Services |
Spinogenix, Inc.
Spinogenix, Inc. Pharmaceuticals: MajorHealth Technology Develops neurorestorative therapeutics | Health Technology |
Amydis, Inc.
Amydis, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a pharmaceutical company that focused on developing chemistry to detect diseases | Commercial Services |
SAB Sciences, Inc.
SAB Sciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical development company | Health Technology |
Lunac Therapeutics Ltd.
Lunac Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Engages in identification and development of anticoagulants | Health Technology |
Big Cypress Acquisition Corp.
 Big Cypress Acquisition Corp. Financial ConglomeratesFinance Operates as a blank check company | Finance |
SAB Biotherapeutics, Inc.
 SAB Biotherapeutics, Inc. BiotechnologyHealth Technology Engages in advancing a new class of immunotherapies | Health Technology |
